glp 1 dementia prevention Are GLP‑1 Meds the Next Frontier in Prevention? GLP-1 and the Degenerating Brain:

2015;86:S2239253X15023701

For researchers and clinicians, these peptides offer distinct tools for different aspects of sexual healthfrom central desire pathways to reproductive hormone regulation to fertility optimization

Results showed that GLP-1 receptor agonists and SGLT2 inhibitors were superior in reducing the risk of MACE when compared to DPP-4 inhibitors (HR 086 [082089] and 086 [082090], respectively), but no difference was found between SGLT2 inhibitors and GLP-1 receptor agonists in reducing rate of MACE (HR of 101 (094107)) (68)

The impact of coenzyme Q 10 on metabolic and cardiovascular disease profiles in diabetic patients: A systematic review and meta-analysis of randomized controlled trials

He needed to go meet a friend for lunch